Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time ...

The Federal Reserve voted to leave its short-term interest rate unchanged as expected, despite mounting pressure ...

The Federal Reserve voted to leave its short-term interest rate unchanged as expected, despite mounting pressure ...

Q2 2025 Management View Gregory Stephen Smith, CEO, reported that "strength in AI compute is more than offsetting lower demand in auto and industrial end markets" and that visibility is starting to ...

Ionis Pharmaceuticals Q2 2025 earnings highlight strong Tryngolza sales, increased 2025 revenue guidance, and upcoming Donidalorsen FDA approval.

Good morning, and welcome to Ionis Second Quarter 2025 Financial Results Conference Call. As a reminder, this call is being recorded. At this time, I would like to turn the call over to Wade Walke, ...

Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people around the world achieve their ...